CARB-X
CARB-X Awards $1M Each to Prompt Diagnostics, Fuse Diagnostics for Point-of-Care STI Tests
The funds will support the development of Prompt's test for drug resistant Neisseria gonorrhoeae and Fuse's test for N. gonorrhoeae and Chlamydia trachomatis.
Scout Nabs $1M CARB-X Award for Point-of-Care Molecular STI Test
The company plans to use the funding to demonstrate proof of concept and feasibility for a rapid test to detect chlamydia and gonorrhea.
Visby Medical Secures $1.8M From CARB-X for Gonorrhea and Drug Resistance MDx
The portable, instrument-free PCR test will be used to detect infections resistant to the frontline antibiotic ciprofloxacin and help reduce use of ceftriaxone.
Avails Medical Submits eQUANT System to FDA, Awarded Additional $5.4M from CARB-X
The automated system aims to replace the bacterial subculture step in antimicrobial susceptibility testing for bloodstream infections.
Day Zero Diagnostics Secures Additional $8.2M From CARB-X
The funding will support product development for Day Zero's whole-genome sequencing and machine learning-based diagnostic.